IBT
ILMN icon

International Biotechnology Trust’s Illumina ILMN Stock Holding History

International Biotechnology Trust’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$6.93M Hold
51,914
– – 2.34% 17
2023
Q2 		$9.46M Buy
51,914
+24,672
+91% +$4.99M 2.88% 12
2023
Q1 		$6.16M Sell
27,242
-20,560
-43% -$4.21M 1.72% 20
2022
Q4 		$9.4M Buy
47,802
+22,102
+86% +$4.58M 2.9% 10
2022
Q3 		$4.77M Buy
25,700
+16,602
+182% +$3.28M 1.53% 21
2022
Q2 		$48K Sell
9,098
-40,246
-82% -$10.3M 0.5% 44
2022
Q1 		$10.8M Buy
49,344
+10,794
+28% +$3.65M 2.43% 16
2021
Q4 		$14.3M Buy
38,550
+10,794
+39% +$4.09M 3.18% 11
2021
Q3 		$10.9M Buy
+27,756
New +$12.8M 2.64% 12
2021
Q2 		– Sell
-16,756
Closed -$6.26M – 69
2021
Q1 		$6.26M Buy
+16,756
New +$6.83M 1.66% 20
2020
Q1 		– Sell
-25,803
Closed -$8.32M – 59
2019
Q4 		$8.32M Hold
25,803
– – 3% 12
2019
Q3 		$7.64M Hold
25,803
– – 3.53% 10
2019
Q2 		$9.24M Hold
25,803
– – 3.43% 11
2019
Q1 		$7.8M Sell
25,803
-8,738
-25% -$2.55M 2.88% 11
2018
Q4 		$7.92M Sell
34,541
-18,504
-35% -$5.73M 4.91% 7
2018
Q3 		$14.5M Buy
53,045
+6,785
+15% +$2.17M 6.9% 2
2018
Q2 		$12.6M Buy
+46,260
New +$11.8M 4.83% 4
2017
Q3 		– Sell
-14,023
Closed -$2.37M – 57
2017
Q2 		$2.37M Sell
14,023
-45,232
-76% -$7.83M 0.9% 34
2017
Q1 		$9.84M Buy
59,255
+1,748
+3% +$275K 3.77% 9
2016
Q4 		$7.16M Buy
+57,507
New +$7.75M 3.23% 13

Other funds holding ILMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

International Biotechnology Trust's ILMN Position: Q3 2023 in Review

International Biotechnology Trust held its Illumina (ILMN) position steady in Q3 2023 at 51,914 shares worth $6.93M. The position accounts for 2.34% of the portfolio, ranked #17.

International Biotechnology Trust first reported a position in ILMN in Q4 2016 and has held it in 20 quarters since. The position peaked at $14.5M in Q3 2018. 819 funds tracked by Wall St. Rank hold ILMN as of Q3 2023.

  • International Biotechnology Trust held 51,914 shares of Illumina worth $6.93M as of Q3 2023.
  • International Biotechnology Trust left its Illumina share count unchanged in Q3 2023.
  • Illumina made up 2.34% of International Biotechnology Trust's portfolio in Q3 2023, its #17 holding.
  • International Biotechnology Trust first reported a position in Illumina in Q4 2016 and has held it in 20 quarters since.
  • International Biotechnology Trust's Illumina position peaked at $14.5M in Q3 2018.
  • 819 funds tracked by Wall St. Rank held Illumina as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.